Cargando…
Vaccination reduces viral load and accelerates viral clearance in SARS-CoV-2 Delta variant-infected patients
OBJECTIVE: The purpose of this study was to investigate vaccine effectiveness in relieving symptoms in patients with the SARS-CoV-2 delta (B.1.617.2) variant. METHODS: In this retrospective study, 31 patients did not receive any vaccine (non-vaccination, NV), 21 patients received 1-dose of inactivat...
Autores principales: | Li, Hongxia, Li, Yanzi, Liu, Junhui, Liu, Jianlin, Han, Jianfeng, Yang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991402/ https://www.ncbi.nlm.nih.gov/pubmed/36862600 http://dx.doi.org/10.1080/07853890.2023.2166681 |
Ejemplares similares
-
Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Cadegiani, Flavio A, et al.
Publicado: (2021) -
Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load
por: Kennedy-Shaffer, Lee, et al.
Publicado: (2021) -
Correlation of Viral Load With the Clinical and Biochemical Profiles of COVID-19 Patients
por: Atique, Muhammad, et al.
Publicado: (2021) -
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness
por: Marc, Aurélien, et al.
Publicado: (2021) -
A randomized, double-blind study on the efficacy of oral domperidone versus placebo for reducing SARS-CoV-2 viral load in mild-to-moderate COVID-19 patients in primary health care
por: Rabanal Basalo, Alejandro, et al.
Publicado: (2023)